Researchers from University Hospital Zurich and the University of Liverpool analyzed electronic health records from over 250 million patients within the TriNetX network to determine the impact of auditory intervention. While the study found no significant link between hearing aid use and dementia risk across the general hearing-impaired population or those with conditions like stroke and diabetes, the outcome for epilepsy patients was distinct. The 23% reduction in risk translates to an absolute decline of 2.7 percentage points over a five-year period, effectively preventing one dementia case for every 37 users.
In section Releases
Hearing aids linked to lower dementia risk for epilepsy patients
Patients managing both epilepsy and hearing loss could lower their dementia risk by 23% through the use of hearing aids. Data presented at the 2026 European Academy of Neurology Congress reveals this significant protective effect, suggesting that correcting sensory impairment provides specific cognitive benefits for this high-risk group.
Lead author Dr. Carolina Ferreira-Atuesta attributes this result to the concept of cognitive reserve. Because epilepsy often compromises the brain's ability to compensate for neurological strain, removing the additional burden of untreated hearing loss provides a measurable safeguard. The researchers suggest that because epilepsy patients are already frequent users of healthcare services, integrating regular hearing screenings into their routine clinical care is a practical and necessary step to mitigate long-term cognitive decline.
Comments (0)
No comments yet. Be the first!